Europe — EMA
Lacosamida Aurovitas
GNH USA supplies Lacosamida Aurovitas (Lacosamide), a sodium channel blocker for partial‑onset seizures.
Request sourcing
What is Lacosamide?
Lacosamide, the active ingredient in Lacosamida Aurovitas, is a sodium channel blocker presented as an oral dosage form for oral use. It is used as adjunctive therapy to control partial‑onset seizures in patients with epilepsy.
GNH USA supplies Lacosamida Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.
What is Lacosamide used for?
Lacosamide is an antiepileptic drug indicated for seizure disorders.
Partial‑onset seizures: reduces seizure frequency when added to existing therapy Focal seizures: provides adjunctive control in patients with refractory focal epilepsy Epilepsy (generalized): contributes to overall seizure management as part of combination therapy
What are the side effects of Lacosamide?
Lacosamide may cause a range of adverse reactions, varying from mild to severe.
Common Side Effects: - Dizziness - Headache - Nausea - Fatigue - Blurred vision - Coordination problems
Serious or Rare Side Effects: - Cardiac arrhythmias (e.g., PR interval prolongation) - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Hypersensitivity reactions (e.g., anaphylaxis) - Mood changes or suicidal ideation
What precautions apply to Lacosamide?
When prescribing Lacosamide, clinicians should consider several precautionary measures. - Cardiac monitoring: assess ECG for PR interval changes - Renal function: adjust dose in severe impairment - Hepatic function: use caution in patients with liver disease - Discontinuation: avoid abrupt cessation to prevent seizure worsening - Store at room temperature: keep in original container, protect from moisture
What does Lacosamide interact with?
Lacosamide can interact with other medicines, requiring attention to potential changes in efficacy or safety.
Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin): may markedly reduce lacosamide levels - Concurrent use with other sodium‑channel blockers (e.g., lamotrigine, topiramate): may increase risk of CNS depression
Moderate Interactions (Monitor Closely): - Hormonal contraceptives: may decrease contraceptive effectiveness - Alcohol: may enhance dizziness and sedation - Other antiepileptic drugs: may require dose adjustments to maintain seizure control
Frequently asked questions
What is Lacosamida Aurovitas used for?+
How does lacosamide work?+
What is the usual dose of Lacosamida Aurovitas?+
Is Lacosamida Aurovitas safe during pregnancy or breastfeeding?+
How do I order Lacosamida Aurovitas from GNH USA?+
How does lacosamide compare with other antiepileptic drugs?+
What are the storage and handling requirements for Lacosamida Aurovitas?+
How is Lacosamida Aurovitas administered?+
What are the most serious risks associated with lacosamide?+
Who should not use Lacosamida Aurovitas?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo